146 related articles for article (PubMed ID: 16908288)
1. FK778 and tacrolimus combination therapy to control acute rejection after pig intestinal transplantation.
Alessiani M; Abbiati F; Zonta S; Zitelli E; Bardone M; Cobianchi L; Viganò J; Doni M; Mazzilli M; Dominioni T; Kabiri D; Bottazzi A; Morbini P; Molinaro MD; Dionigi P
Transplant Proc; 2006; 38(6):1809-11. PubMed ID: 16908288
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of malononitrilamide FK778 in a preclinical model of small bowel transplantation.
Alessiani M; Zonta S; Abbiati F; Cobianchi L; Bardone M; Zitelli E; Doni M; Viganò J; Mazzilli M; Lovisetto F; Dominioni T; Dionigi B; Lusona B; Morbini P; Molinaro MD; Dionigi P
Transplant Proc; 2005; 37(6):2719-21. PubMed ID: 16182793
[TBL] [Abstract][Full Text] [Related]
3. Prolonged survival with FK778 (malononitrilamide) monotherapy after small bowel transplantation: a large animal study.
Zonta S; Alessiani M; Viganò J; Doni M; Bardone M; Dominioni T; De Martino M; Scaglione M; Vicini E; Filisetti C; Biroli A; Bottazzi A; Villa C; Morbini P; Dionigi P
Transplant Proc; 2007; 39(6):2021-3. PubMed ID: 17692681
[TBL] [Abstract][Full Text] [Related]
4. Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates.
Qi S; Zhu S; Xu D; Wang X; Ouyang J; Jiang W; Vu MD; Bilolo K; Ma A; Johnson S; Daloze P; Bekersky I; Fitzsimmons WE; Chen H
Transplantation; 2003 Apr; 75(8):1124-8. PubMed ID: 12717189
[TBL] [Abstract][Full Text] [Related]
5. FK778 does not impair intestinal allograft absorption in a preclinical model of total small bowel transplantation.
Zonta S; Doni M; Alessiani M; Abbiati F; Bardone M; Lovisetto F; Cobianchi L; Vigano J; De Martino M; Kabiri D; Dominioni T; Scaglione M; Bottazzi A; Poggi P; Dionigi P
Transplant Proc; 2006; 38(6):1805-8. PubMed ID: 16908287
[TBL] [Abstract][Full Text] [Related]
6. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
Deuse T; Schrepfer S; Pelletier MP; Fischbein MP; Robbins RC; Reichenspurner H
Transplant Proc; 2007 Mar; 39(2):569-72. PubMed ID: 17362784
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy of malononitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts.
Vu MD; Qi S; Wang X; Jiang W; Ma A; Xu D; Bekersky I; Fitzsimmons WE; Wu J; Chen H
Transplantation; 2003 May; 75(9):1455-9. PubMed ID: 12792496
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat.
Bilolo KK; Ouyang J; Wang X; Zhu S; Jiang W; Qi S; Xu D; Hebert MJ; Bekersky I; Fitzsimmons WE; Chen H
Transplantation; 2003 Jun; 75(11):1881-7. PubMed ID: 12811249
[TBL] [Abstract][Full Text] [Related]
9. FK778 in experimental xenotransplantation: a detailed analysis of drug efficacy.
Schrepfer S; Deuse T; Koch-Nolte F; Krieger T; Haddad M; Schäfer H; Pelletier MP; Robbins RC; Reichenspurner H
J Heart Lung Transplant; 2007 Jan; 26(1):70-7. PubMed ID: 17234520
[TBL] [Abstract][Full Text] [Related]
10. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
Rintala JM; Savikko J; Rintala SE; von Willebrand E
Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
[TBL] [Abstract][Full Text] [Related]
11. FK778 controls acute rejection after rat liver allotransplantation showing positive interaction with FK506.
Yamamoto S; Okuda T; Yamasaki K; Tanaka H; Takemura S; Minamiyama Y; Ikeda K; Hirohashi K; Suehiro S
Transplant Proc; 2005; 37(1):126-9. PubMed ID: 15808570
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation.
Gruessner RW; Fryer JP; Fasola C; Nakhleh RE; Gruessner AC; Kim S; Dunn DL; Pirenne J; Bekersky I; Benedetti E
Transplantation; 1995 Jan; 59(2):164-71. PubMed ID: 7530871
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression with a combination of the leflunomide analog, FK778, and microemulsified cyclosporine for renal transplantation in mongrel dogs.
Kyles AE; Gregory CR; Griffey SM; Bernsteen L; Pierce J; Lilja HS; Morris RE
Transplantation; 2003 Apr; 75(8):1128-33. PubMed ID: 12717190
[TBL] [Abstract][Full Text] [Related]
14. Early outcome of different steroid-free regimens in small bowel transplantation: a large-animal study.
Doni M; Cobianchi L; Alessiani M; Zonta S; Abbiati F; Morbini P; Bardone M; Mazzilli M; Viganò J; De Martino M; Dominioni T; Dionigi B; Molinaro MD; Bottazzi A; Dionigi P
Transplant Proc; 2006; 38(6):1812-4. PubMed ID: 16908289
[TBL] [Abstract][Full Text] [Related]
15. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
Rintala JM; Savikko J; Rintala SE; von Willebrand E
Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
[TBL] [Abstract][Full Text] [Related]
16. The new malononitrilamide immunosuppressant FK778 prolongs corneal allograft survival in the rat keratoplasty model.
Birnbaum F; Schwartzkopff J; Scholz C; Reis A; Reinhard T
Eye (Lond); 2007 Dec; 21(12):1516-23. PubMed ID: 17401326
[TBL] [Abstract][Full Text] [Related]
17. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH
Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186
[TBL] [Abstract][Full Text] [Related]
18. FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survival.
Schrepfer S; Deuse T; Schäfer H; Reichenspurner H
Transpl Int; 2005 Feb; 18(2):215-20. PubMed ID: 15691275
[TBL] [Abstract][Full Text] [Related]
19. 2005 Dr. Gary J. Becker Young Investigator Award: periprocedural oral administration of the leflunomide analogue FK778 inhibits neointima formation in a double-injury rat model of restenosis.
Jahnke T; Schäfer FK; Bolte H; Rector L; Schäfer PJ; Brossmann J; Fändrich F; Hedderich J; Heller M; Müller-Hülsbeck S
J Vasc Interv Radiol; 2005 Jul; 16(7):903-10. PubMed ID: 16002499
[TBL] [Abstract][Full Text] [Related]
20. FK778 and tacrolimus prevent the development of obliterative airway disease after heterotopic rat tracheal transplantation.
Deuse T; Schrepfer S; Koch-Nolte F; Haddad M; Schwedhelm E; Böger R; Schäfer H; Detter C; Reichenspurner H
J Heart Lung Transplant; 2005 Nov; 24(11):1844-54. PubMed ID: 16297791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
